DNA methylation and microRNA dysregulation in cancer
- PMID: 22902148
- PMCID: PMC5528344
- DOI: 10.1016/j.molonc.2012.07.007
DNA methylation and microRNA dysregulation in cancer
Abstract
DNA methylation plays a key role in the silencing of numerous cancer-related genes, thereby affecting a number of vital cellular processes, including the cell cycle checkpoint, apoptosis, signal transduction, cell adhesion and angiogenesis. Also widely altered in human malignancies is the expression of microRNAs (miRNAs), a class of small noncoding RNAs that act as posttranscriptional regulators of gene expression. Furthermore, emerging evidence now supports the idea that DNA methylation is crucially involved in the dysregulation of miRNAs in cancer. This is in part the result of technological advances that enable more comprehensive analysis of miRNA expression profiles and the epigenome in cancer cells, which has led to the identification of a number of epigenetically regulated miRNAs. As with protein-coding genes, it appears that miRNA genes involved in regulating cancer-related pathways are silenced in association with CpG island hypermethylation. In addition, methylation in CpG island shore regions and DNA hypomethylation also appear to contribute to miRNA dysregulation in cancer. Aberrant DNA methylation of miRNA genes is a potentially useful biomarker for detecting cancer and predicting its outcome. Moreover, re-expression of miRNAs and the replacement of tumor suppressive miRNAs using miRNA mimics or expression vectors could be effective approaches to cancer therapy.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
MicroRNA Methylation in Colorectal Cancer.Adv Exp Med Biol. 2016;937:109-22. doi: 10.1007/978-3-319-42059-2_6. Adv Exp Med Biol. 2016. PMID: 27573897 Review.
-
Epigenetic alteration and microRNA dysregulation in cancer.Front Genet. 2013 Dec 3;4:258. doi: 10.3389/fgene.2013.00258. Front Genet. 2013. PMID: 24348513 Free PMC article. Review.
-
Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells.Cancer Sci. 2012 May;103(5):837-45. doi: 10.1111/j.1349-7006.2012.02236.x. Epub 2012 Mar 13. Cancer Sci. 2012. PMID: 22320679 Free PMC article. Review.
-
Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.Adv Exp Med Biol. 2016;927:109-35. doi: 10.1007/978-981-10-1498-7_4. Adv Exp Med Biol. 2016. PMID: 27376733 Review.
-
Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells.PLoS One. 2011;6(6):e20628. doi: 10.1371/journal.pone.0020628. Epub 2011 Jun 16. PLoS One. 2011. PMID: 21698188 Free PMC article.
Cited by
-
Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.Sci Rep. 2018 Sep 26;8(1):14373. doi: 10.1038/s41598-018-32393-3. Sci Rep. 2018. PMID: 30258192 Free PMC article.
-
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression.Sci Rep. 2023 Jan 18;13(1):1003. doi: 10.1038/s41598-023-27415-8. Sci Rep. 2023. PMID: 36653507 Free PMC article.
-
Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive Lymphomas.Cancers (Basel). 2017 Aug 3;9(8):100. doi: 10.3390/cancers9080100. Cancers (Basel). 2017. PMID: 28771164 Free PMC article. Review.
-
Folate deficiency disturbs hsa-let-7 g level through methylation regulation in neural tube defects.J Cell Mol Med. 2017 Dec;21(12):3244-3253. doi: 10.1111/jcmm.13228. Epub 2017 Jun 19. J Cell Mol Med. 2017. PMID: 28631291 Free PMC article.
-
Epigenetic silencing of microRNA-199a-5p promotes the proliferation of non-small cell lung cancer cells by increasing AKAP1 expression.Oncol Lett. 2021 Jun;21(6):434. doi: 10.3892/ol.2021.12695. Epub 2021 Mar 31. Oncol Lett. 2021. PMID: 33868472 Free PMC article.
References
-
- Agirre, X. , Vilas-Zornoza, A. , Jimenez-Velasco, A. , Martin-Subero, J.I. , Cordeu, L. , Garate, L. , San Jose-Eneriz, E. , Abizanda, G. , Rodriguez-Otero, P. , Fortes, P. , Rifon, J. , Bandres, E. , Calasanz, M.J. , Martin, V. , Heiniger, A. , Torres, A. , Siebert, R. , Roman-Gomez, J. , Prosper, F. , 2009. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res. 69, 4443–4453. - PubMed
-
- Ando, T. , Yoshida, T. , Enomoto, S. , Asada, K. , Tatematsu, M. , Ichinose, M. , Sugiyama, T. , Ushijima, T. , 2009. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer. 124, 2367–2374. - PubMed
-
- Bandres, E. , Agirre, X. , Bitarte, N. , Ramirez, N. , Zarate, R. , Roman-Gomez, J. , Prosper, F. , Garcia-Foncillas, J. , 2009. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer. 125, 2737–2743. - PubMed
-
- Bommer, G.T. , Gerin, I. , Feng, Y. , Kaczorowski, A.J. , Kuick, R. , Love, R.E. , Zhai, Y. , Giordano, T.J. , Qin, Z.S. , Moore, B.B. , MacDougald, O.A. , Cho, K.R. , Fearon, E.R. , 2007. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298–1307. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials